ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/004/SRR17043504/SRR17043504_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/006/SRR17043506/SRR17043506_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/096/SRR17043496/SRR17043496_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/002/SRR17043502/SRR17043502_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/000/SRR17043500/SRR17043500_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/001/SRR17043501/SRR17043501_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/005/SRR17043505/SRR17043505_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/002/SRR17043502/SRR17043502_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/001/SRR17043501/SRR17043501_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/098/SRR17043498/SRR17043498_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/097/SRR17043497/SRR17043497_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/007/SRR17043507/SRR17043507_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/099/SRR17043499/SRR17043499_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/005/SRR17043505/SRR17043505_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/003/SRR17043503/SRR17043503_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/097/SRR17043497/SRR17043497_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/098/SRR17043498/SRR17043498_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/006/SRR17043506/SRR17043506_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/099/SRR17043499/SRR17043499_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/004/SRR17043504/SRR17043504_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/096/SRR17043496/SRR17043496_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/007/SRR17043507/SRR17043507_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/003/SRR17043503/SRR17043503_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR170/000/SRR17043500/SRR17043500_2.fastq.gzprimaryOK200GenomicsShuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicinehttps://www.ebi.ac.uk/ena/browser/view/PRJNA783810xref:EuropePMC:PMC10186707Symmetric dimethylarginine (SDMA) is regarded as an independent cardiovascular risk factor in patients with chronic kidney diseases. Renal interstitial fibrosis is a common pathway of all kinds of chronic kidney diseases progressing to the end stage of renal diseases. In this study we investigated the role of SDMA in renal fibrosis and its underlining mechanisms.ENAN(4)-dimethylarginine, N(5)-(N, SDMA, N(5)-((methylamino)(methylimino)methyl)-, N(G2)-dimethylarginine, N'-dimethylcarbamimidoyl)-L-ornithine, N'-dimethylamidino)-L-ornithine, N'-Dimethylarginine, N, omega-N(G), N''-dimethylcarbamimidamido)pentanoic acid, MOD_RES Symmetric dimethylarginine, N(3), N'G-dimethyl-L-arginine, N'(G)-dimethyl-L-arginine, N(G1), N(5)-[bis(methylamino)methylene]-L-ornithine, N5-((methylamino)(methylimino)methyl)-L-ornithine, sDMA arginine, L-ornithine, (2S)-2-amino-5-(N', symmetric dimethylarginine, N(G2)-Dimethylarginine, renal fibrosis, Omega-N-methylated arginine, N''-dimethylguanidino)pentanoic acid, Guanidino-N(1), N(4)-dimethyl-L-arginine, N'-dimethylarginine, (S)-2-amino-5-(N', N(2)-dimethylarginine, guanidino-N(1), kidney fibrosis., MOD_RES Omega-N-methylated arginine, N(G), N'(G)-dimethylarginine, NG, Symmetric dimethylargininefalseSymmetric dimethylarginine inhibits renal fibrosis2023-05-192022-10-07PRJNA783810